Literature DB >> 22083666

Murine model of neuromuscular electrical stimulation on squamous cell carcinoma: potential implications for dysphagia therapy.

Gary Linkov1, Ryan C Branski, Milan Amin, Natalya Chernichenko, Chun-Hao Chen, Gad Alon, Susan Langmore, Richard J Wong, Dennis H Kraus.   

Abstract

BACKGROUND: Dysphagia is a potential consequence of treatment for head and neck cancer. Neuromuscular electrical stimulation (NMES) has evolved as a treatment option, with the goal of improved swallow function in patients with chronic dysphagia. However, the effects of NMES on tumorigenicity are unknown and often confound the initiation of this therapy, potentially limiting its efficacy in treating patients with head and neck cancer.
METHODS: Squamous cell carcinoma was grown in the flank of athymic, nude mice. Mice were randomized into treatment and control groups; the experimental group received daily NMES directly to the flank for 8 days.
RESULTS: Tumor volumes, recorded on days 0, 3, 7, and 10, demonstrated no significant differences between groups on each day of measurement. Immunohistochemical analysis of apoptosis, proliferation, and vascularization also failed to demonstrate statistically significant differences between treated and untreated groups.
CONCLUSIONS: NMES does not promote the growth of underlying tumor in our model. These data may provide preliminary evidence that applying electrical stimulation over the muscles of the anterior neck does not increase the risk of tumorigenicity. Early initiation of NMES in this challenging population may be feasible from an oncologic standpoint.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22083666      PMCID: PMC3781933          DOI: 10.1002/hed.21935

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  30 in total

Review 1.  Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.

Authors:  Bharat B Mittal; Barbara R Pauloski; Daniel J Haraf; Harold J Pelzer; Athanassios Argiris; Everett E Vokes; Alfred Rademaker; Jerilyn A Logemann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-12-01       Impact factor: 7.038

Review 2.  Neuromuscular electrical stimulation and voluntary exercise.

Authors:  K Hainaut; J Duchateau
Journal:  Sports Med       Date:  1992-08       Impact factor: 11.136

Review 3.  Modified cell proliferation due to electrical currents.

Authors:  L Vodovnik; D Miklavcic; G Sersa
Journal:  Med Biol Eng Comput       Date:  1992-07       Impact factor: 2.602

4.  Electrolysis with different electrode materials and combined with irradiation for treatment of experimental rat tumors.

Authors:  L Samuelsson; L Jönsson; I L Lamm; C J Lindén; S B Ewers
Journal:  Acta Radiol       Date:  1991-03       Impact factor: 1.990

5.  Electric fields and proliferation in a chronic wound model.

Authors:  R Goldman; S Pollack
Journal:  Bioelectromagnetics       Date:  1996       Impact factor: 2.010

6.  Electrical wiring configurations and childhood cancer.

Authors:  N Wertheimer; E Leeper
Journal:  Am J Epidemiol       Date:  1979-03       Impact factor: 4.897

7.  Electric stimulation of protein and DNA synthesis in human fibroblasts.

Authors:  G J Bourguignon; L Y Bourguignon
Journal:  FASEB J       Date:  1987-11       Impact factor: 5.191

8.  Effect of low level direct current on in vivo tumor growth in hamsters.

Authors:  S L David; D R Absolom; C R Smith; J Gams; M A Herbert
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

9.  Magnetic field exposure from electric appliances and childhood cancer.

Authors:  D A Savitz; E M John; R C Kleckner
Journal:  Am J Epidemiol       Date:  1990-05       Impact factor: 4.897

10.  Disruption of cancer cell replication by alternating electric fields.

Authors:  Eilon D Kirson; Zoya Gurvich; Rosa Schneiderman; Erez Dekel; Aviran Itzhaki; Yoram Wasserman; Rachel Schatzberger; Yoram Palti
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.